These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35611916)

  • 21. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure.
    Hystad ME; Klinge R; Spurkland A; Attramadal H; Hall C
    Scand J Clin Lab Invest; 2000 Jul; 60(4):299-309. PubMed ID: 10943600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
    Grantham JA; Borgeson DD; Burnett JC
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
    Vesely DL
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial natriuretic peptides in the diagnosis and treatment of congestive heart failure.
    Vesely DL
    Congest Heart Fail; 1999; 5(4):171-179. PubMed ID: 12189309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction.
    Lainchbury JG; Richards AM; Nicholls MG; Hunt PJ; Ikram H; Espiner EA; Yandle TG; Begg E
    Hypertension; 1997 Sep; 30(3 Pt 1):398-404. PubMed ID: 9314423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
    Karmpaliotis D; Kirtane AJ; Ruisi CP; Polonsky T; Malhotra A; Talmor D; Kosmidou I; Jarolim P; de Lemos JA; Sabatine MS; Gibson CM; Morrow D
    Chest; 2007 Apr; 131(4):964-71. PubMed ID: 17426196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
    McCullough PA; Kuncheria J; Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with congestive heart failure.
    Tamura K; Takahashi N; Nakatani Y; Onishi S; Iwasaka T
    Gerontology; 2001; 47(1):46-51. PubMed ID: 11244291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea.
    Steg PG; Joubin L; McCord J; Abraham WT; Hollander JE; Omland T; Mentré F; McCullough PA; Maisel AS
    Chest; 2005 Jul; 128(1):21-9. PubMed ID: 16002911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery.
    Mekontso-Dessap A; Tual L; Kirsch M; D'Honneur G; Loisance D; Brochard L; Teboul JL
    Br J Anaesth; 2006 Dec; 97(6):777-82. PubMed ID: 17046851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapy.
    Enomoto K; Yamabe H; Toyama K; Matsuzawa Y; Yamamuro M; Uemura T; Morihisa K; Iwashita S; Kaikita K; Sugiyama S; Ogawa H
    J Cardiol; 2011 Jul; 58(1):69-73. PubMed ID: 21493043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between B-type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis.
    Maeder MT; Weber L; Ammann P; Buser M; Ehl NF; Gerhard M; Brenner R; Haager PK; Maisano F; Rickli H
    ESC Heart Fail; 2020 Apr; 7(2):577-587. PubMed ID: 31994357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure.
    Dokainish H; Zoghbi WA; Lakkis NM; Ambriz E; Patel R; Quinones MA; Nagueh SF
    J Am Coll Cardiol; 2005 Apr; 45(8):1223-6. PubMed ID: 15837253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.